1Vogel F. Moderne probleme der Humangenetik [J]. Ergeb Inn Med Kinderhilkd, 1959,12(52):125.
2Gonzalez FJ, Skoda RC, Kimura S, et al. Characterization of the common genetic defect in humans dificient in debrisoquine metabolism [J]. Nature, 1988,331(6155):442-446.
3Wieczorek SJ, Tsongalis GJ. Pharmacogenomics: will it change the field of medicine? [J] Clin Chim Acta, 2001,308(1-2):1-8.
4Grant S. Pharmacogenetics and pharmacogenomics: tailored drug therapy for the 21st century [J]. Trends Pharmacol Sci, 2001,22(1):3-4.
5Norton, Ronald M. Clinical pharmacogenomics: applications in pharmaceutical R&D [J]. Drug Discov Today, 2001,6(4):180-185.
6Peet NP, Bey P. Pharmacogenomics: challenges and opportunities [J]. Drug Discov Today, 2001,6(10):495-498.
7Bestenaves D, Thomas F. New advances in pharmaco-genomics [J]. Curr Opin Chem Biol, 2000,4(4):440-444.
8Meyer U. Pharmacogenetics and adverse drug reactions [J]. Lancet, 2000,356(9242):1667-1671.
9Brookes A. The essence of SNPs [J]. Gene, 1999,234(2):177-186.
10Roses A. How will pharmacogenetics impact the future of research and development? [J] Drug Discov Today, 2001,6(2):59-60.
